Orchid Pharma Limited (NSE:ORCHPHARMA)
India · Delayed Price · Currency is INR 569.40
+3.70 (0.65%)
Apr 17, 2026, 3:29 PM IST
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 28.88 billion as of April 17, 2026. Its market cap has decreased by -27.86% in one year.
Market Cap
28.88B
Enterprise Value
30.21B
Revenue
8.11B
Ranking
n/a
PE Ratio
151.04
Stock Price
569.40
Market Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 28.88B, an increase of 3,870.51%. That is a compound annual growth rate of 96.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 28.88B | -24.98% |
| Dec 31, 2025 | 38.49B | -58.00% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 63.70B |
| Sun Pharma Advanced Research Company | 48.93B |
| Innova Captab | 42.04B |
| RPG Life Sciences | 31.74B |
| Solara Active Pharma Sciences | 23.72B |
| Indoco Remedies | 20.13B |
| Windlas Biotech | 18.26B |
| Beta Drugs | 14.04B |